Asia-pacific Skin Cancer Diagnostics Market Forecast 2023-2032

The Asia-Pacific skin cancer diagnostics market is set to project a 7.76% CAGR during 2023-2032. The increasing awareness regarding the importance of early detection and regular screening is contributing to increased demands for diagnostic tests in the region.

MARKET INSIGHTS

China, Indonesia, South Korea, Japan, Australia & New Zealand, Vietnam, Thailand, India, and Rest of Asia-Pacific are evaluated for the growth assessment of the Asia-Pacific skin cancer diagnostics market. In Japan, the market growth is driven by the increasing prevalence of skin cancer and government initiatives. For instance, the government accords the largest share of expenses, more than 38%, through the national treasury and municipality funds. Besides, new medical tools are being launched by market players. For instance, PHC Corporation and US-based NovaScan announced a collaboration in April 2023. They aim to explore the feasibility of MarginScan, an investigational 'ex vivo' medical device to support the detection of non-melanoma skin cancers (NMSC).

Further, in South Korea, the market growth is attributed to considerable advancements in dermatology-related technologies and growing skin cancer awareness among the population. Also, as per the 2020 World Health Organization (WHO) 2020 data, skin cancer deaths in the country constituted 0.23% of total deaths. Additionally, the skin cancer melanoma treatment costs between $3150 to $3850. Similarly, the per capita spending has been on a steady rise in the country. Such factors boost the market growth in these countries.

COMPETITIVE INSIGHTS

Some of the eminent companies operating in the market include: F Hoffmann-La Roche Ltd, Michelson Diagnostics Ltd, AMLo Biosciences Limited, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 51885

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. INCREASING APPLICATION OF AI AND MACHINE LEARNING IN SKIN CANCER DIAGNOSIS TOOLS
- 2.5.2. EXPANDING MARKET DEMAND FOR SKIN CANCER DIAGNOSTICS IN AUSTRALIA

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASING PREVALENCE OF SKIN CANCER
- 3.1.2. GROWING AWARENESS ABOUT SKIN CANCER DIAGNOSIS & TREATMENT
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS IN SKIN CANCER DIAGNOSTIC PRODUCTS
3.2. KEY RESTRAINTS
- 3.2.1. HIGH COSTS ASSOCIATED WITH SKIN CANCER TREATMENTS
- 3.2.2. STRINGENT REGULATORY FRAMEWORK
- 3.2.3. LACK OF SKILLED MEDICAL PROFESSIONALS

4. KEY ANALYTICS

4.1. PARENT MARKET ANALYSIS
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
- 4.6.1. RESEARCH AND DEVELOPMENT
- 4.6.2. MANUFACTURING
- 4.6.3. MARKETING AND SALES
- 4.6.4. DISTRIBUTION AND LOGISTICS
- 4.6.5. TRAINING AND SUPPORT

5. MARKET BY TYPE

5.1. MELANOMA
5.2. NON-MELANOMA

6. MARKET BY GENDER

6.1. MALE
6.2. FEMALE

7. MARKET BY SCREENING TYPE

7.1. SKIN BIOPSY
7.2. DERMATOSCOPY
7.3. LYMPH NODE
7.4. BIOPSY IMAGING TESTS
7.5. BLOOD TESTS

8. GEOGRAPHICAL ANALYSIS

8.1. ASIA-PACIFIC
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET DRIVERS
- 8.1.3. ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET CHALLENGES
- 8.1.4. KEY PLAYERS IN ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. CHINA
  - 8.1.5.1.1. CHINA SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES
  - 8.1.5.2. JAPAN
  - 8.1.5.2.1. JAPAN SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES
  - 8.1.5.3. INDIA
  - 8.1.5.3.1. INDIA SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES
  - 8.1.5.4. SOUTH KOREA
  - 8.1.5.4.1. SOUTH KOREA SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES
  - 8.1.5.5. INDONESIA
  - 8.1.5.5.1. INDONESIA SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES
  - 8.1.5.6. THAILAND
  - 8.1.5.6.1. THAILAND SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES
  - 8.1.5.7. VIETNAM
  - 8.1.5.7.1. VIETNAM SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES
  - 8.1.5.8. AUSTRALIA & NEW ZEALAND
  - 8.1.5.8.1. AUSTRALIA & NEW ZEALAND SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES
  - 8.1.5.9. REST OF ASIA-PACIFIC
  - 8.1.5.9.1. REST OF ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.2. PARTNERSHIPS & AGREEMENTS
9.2. COMPANY PROFILES
- 9.2.1. AMLO BIOSCIENCES LIMITED
- 9.2.2. BIOMERIEUX SA
- 9.2.3. CASTLE BIOSCIENCES INC
- 9.2.4. DERMLITE LLC
- 9.2.5. DERMTECH INC.
- 9.2.6. F HOFFMANN-LA ROCHE LTD
- 9.2.7. MICHELSON DIAGNOSTICS LTD
- 9.2.8. NERACARE GMBH
- 9.2.9. SKYLINEDX BV
- 9.2.10. VERISKIN INC

Product Code: 51885

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - SKIN CANCER DIAGNOSTICS
TABLE 2: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY GENDER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY GENDER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY SCREENING TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY SCREENING TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: KEY PLAYERS OPERATING IN ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET
TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 7: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY MELANOMA, 2023-2032 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY NON-MELANOMA, 2023-2032 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY GENDER, IN 2022
FIGURE 10: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY MALE, 2023-2032 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY FEMALE, 2023-2032 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY SCREENING TYPE, IN 2022
FIGURE 13: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY SKIN BIOPSY, 2023-2032 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY DERMATOSCOPY, 2023-2032 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY LYMPH NODE, 2023-2032 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY BIOPSY IMAGING TESTS, 2023-2032 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, BY BLOOD TESTS, 2023-2032 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 19: CHINA SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 20: JAPAN SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 21: INDIA SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: SOUTH KOREA SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: INDONESIA SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: THAILAND SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: VIETNAM SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: AUSTRALIA & NEW ZEALAND SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: REST OF ASIA-PACIFIC SKIN CANCER DIAGNOSTICS MARKET, 2023-2032 (IN $ MILLION)